US74834L1008
US74834L1008
Quest Diagnostics Incorporated
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 25.49B EUR | 23.31B EUR | 21.75B EUR | 19.13B EUR |
Enterprise Value | 31.64B EUR | 29.07B EUR | 27.77B EUR | 25.3B EUR |
Valuation Multiples | ||||
Trailing P/E | 24.52x | 21.95x | 21.24x | 24.78x |
Forward P/E | 19.15x | -- | -- | -- |
Price to Sales | 2.21x | 2.02x | 1.93x | 2.28x |
Price to Book | 3.38x | 3.1x | 2.95x | 2.67x |
EV/Revenue | 2.74x | 2.51x | 2.46x | 3.02x |
EV/EBITDA | 13.96x | 12.87x | 12.46x | 15.08x |
Price to FCF (P/FCF) | 28.03x | 17.28x | 16.41x | 16.46x |
EV/FCF | 34.78x | 21.55x | 20.94x | 21.77x |
FCF Yield | 3.57% | 5.79% | 6.1% | 6.07% |